Citation: | XIAN Wenfeng, NIU Peng, ZHANG Lei, LIU Yongxi. Research of correlation between serum interleukin-33 expression level and pulmonary metastasis in children with primary osteosarcoma[J]. Journal of Clinical Medicine in Practice, 2021, 25(2): 77-80. DOI: 10.7619/jcmp.20201051 |
[1] |
KAGER L, TAMAMYAN G, BIELACK S. Novel insights and therapeutic interventions for pediatric osteosarcoma[J]. Future Oncol, 2017, 13(4): 357-368. doi: 10.2217/fon-2016-0261
|
[2] |
孙馨, 郭卫, 杨荣利, 等. 99例骨肉瘤肺转移患者随访结果分析[J]. 中华骨科杂志, 2010, 30(7): 666-671. doi: 10.3760/cma.j.issn.0253-2352.2010.07.008
|
[3] |
LARSEN K M, MINAYA M K, VAISH V, et al. The role of IL-33/ST2 pathway in tumorigenesis[J]. Int J Mol Sci, 2018, 19(9): 2676. doi: 10.3390/ijms19092676
|
[4] |
WANG S Y, ZHAO G Y, ZHAO S J, et al. The effects of interleukin-33 (IL-33) on osteosarcoma cell viability, apoptosis, and epithelial-mesenchymal transition are mediated through the PI3K/AKT pathway[J]. Med Sci Monit, 2020, 26: e920766. http://www.researchgate.net/publication/339441261_The_Effects_of_Interleukin-33_IL-33_on_Osteosarcoma_Cell_Viability_Apoptosis_and_Epithelial-Mesenchymal_Transition_are_Mediated_Through_the_PI3KAKT_Pathway/download
|
[5] |
HONG J, KIM S, LIN P C. Interleukin-33 and ST2 signaling in tumor microenvironment[J]. J Interferon Cytokine Res, 2019, 39(1): 61-71. doi: 10.1089/jir.2018.0044
|
[6] |
邓旭, 熊玉琪, 马波, 等. 白细胞介素-33在非小细胞肺癌患者中的表达及其临床意义[J]. 中华实验外科杂志, 2016, 33(4): 1122-1125. doi: 10.3760/cma.j.issn.1001-9030.2016.04.077
|
[7] |
胡霞, 孙晓滨, 单晶. IL-33及其受体ST2在食管腺癌中的表达及其对肿瘤细胞增殖、迁移与侵袭的影响[J]. 四川医学, 2019, 40(1): 32-37. https://www.cnki.com.cn/Article/CJFDTOTAL-SCYX201901010.htm
|
[8] |
戴鹏, 黄晖, 孙劲, 等. 骨肉瘤患者血浆sST2水平及临床意义[J]. 临床肿瘤学杂志, 2017, 22(10): 891-895. doi: 10.3969/j.issn.1009-0460.2017.10.006
|
[9] |
KANG C, ZHAO J, WANG Y, et al. Relationship of common variants in Interleukin 33 gene with susceptibility and prognosis of osteosarcoma in Han Chinese population[J]. J Cancer, 2019, 10(5): 1138-1144. doi: 10.7150/jca.29086
|
[10] |
GONG T, SU X T, XIA Q, et al. Expression of NF-κB and PTEN in osteosarcoma and its clinical significance[J]. Oncol Lett, 2017, 14(6): 6744-6748. http://pubmedcentralcanada.ca/pmcc/articles/PMC5678349/
|
[11] |
TANG X F, CAO Y, PENG D B, et al. Overexpression of Notch3 is associated with metastasis and poor prognosis in osteosarcoma patients[J]. Cancer Manag Res, 2019, 11: 547-559. doi: 10.2147/CMAR.S185495
|
[12] |
ZHOU Y L, HU J L. Evodiamine induces apoptosis, G2/M cell cycle arrest, and inhibition of cell migration and invasion in human osteosarcoma cells via raf/MEK/ERK signalling pathway[J]. Med Sci Monit, 2018, 24: 5874-5880. doi: 10.12659/MSM.909682
|
[13] |
MEAZZA C, SCANAGATTA P. Metastatic osteosarcoma: a challenging multidisciplinary treatment[J]. Expert Rev Anticancer Ther, 2016, 16(5): 543-556. doi: 10.1586/14737140.2016.1168697
|